FTO has been reported to play a carcinogenic role in AML and promotes cancer cell proliferation and transformation by downregulating the m6A levels on several important cell differentiation related genes such as ASB2 and RARA [66]. This evidence concerns the gene FTO and acute myeloid leukemia.